{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T14:58:00Z","timestamp":1740149880846,"version":"3.37.3"},"reference-count":13,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T00:00:00Z","timestamp":1612396800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cytogenet"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Mantle cell lymphoma (MCL) is derived from na\u00efve CD5+ B-cells with the cytogenetic hallmark translocation 11;14. The presence of additional abnormalities is associated with blastoid variants in MCL (BMCL) and confers a poor prognosis. Many of these tumors also show deletion or loss of heterozygosity (LOH) of the <jats:italic>ATM<\/jats:italic> gene and biallelic <jats:italic>ATM<\/jats:italic> inactivation show significantly higher chromosomal imbalances.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>Here we report a 52\u00a0year-old male who presented to the clinic with worsening dyspnea, fever, chills, diffuse lymphadenopathy, splenomegaly and leukocytosis with blastoid cells circulating in blood. The bone marrow aspirate showed about 40% abnormal blast-looking cells and biopsy revealed a remarkable lymphoid infiltrate. The patient was diagnosed with blastoid variant mantle cell lymphoma (BMCL). Chromosome analysis on bone marrow showed a complex karyotype. FISH analysis from B-cell lymphoma panel showed bi-allelic amplification of <jats:italic>ATM<\/jats:italic> gene. Other abnormalities were present including <jats:italic>CCND1\/IGH<\/jats:italic> fusion, confirming the MCL diagnosis, in addition to RB1 and p53 deletion. High resolution SNP-microarray studies showed complex copy number changes, especially on chromosomes 7 and 11, consistent with chromoanagenesis. Microarray studies also showed LOH at the <jats:italic>ATM<\/jats:italic> locus indicating the amplification seen on FISH is not biallelic.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>To the best of our knowledge, <jats:italic>ATM<\/jats:italic> gene amplification is not previously reported in BMCL and our case suggests a novel mechanism of <jats:italic>ATM<\/jats:italic> inactivation caused by chromoanagenesis resulting in mutant allele specific imbalance with copy number gain.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13039-020-00526-x","type":"journal-article","created":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T16:03:26Z","timestamp":1612454606000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bi-allelic amplification of ATM gene in blastoid variant of mantle cell lymphoma: a novel mechanism of inactivation due to chromoanagenesis?"],"prefix":"10.1186","volume":"14","author":[{"given":"Veronica","family":"Ortega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Mendiola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juana","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"William","family":"Ehman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"You-Wen","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2811-8185","authenticated-orcid":false,"given":"Gopalrao","family":"Velagaleti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,2,4]]},"reference":[{"key":"526_CR1","volume-title":"WHO classification of tumours of haematopoietic and lymphoid tissues","author":"S Swerdlow","year":"2008","unstructured":"Swerdlow S, Campo E, Harris N, Jaffe E, Pileri S, Stein H, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC; 2008."},{"key":"526_CR2","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1038\/nrc2230","volume":"7","author":"P Jares","year":"2007","unstructured":"Jares P, Colomer D, Campo E. Genetic and molecular pathogenesis of mantle cell lymphoma: perspectives for new targeted therapeutics. Nat Rev Cancer. 2007;7:750\u201362.","journal-title":"Nat Rev Cancer"},{"key":"526_CR3","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1111\/j.1365-2141.2008.07124.x","volume":"142","author":"P Jares","year":"2008","unstructured":"Jares P, Campo E. Advances in the understanding of mantle cell lymphoma. Br J Haematol. 2008;142:149\u201365.","journal-title":"Br J Haematol"},{"key":"526_CR4","doi-asserted-by":"publisher","first-page":"95","DOI":"10.3343\/alm.2012.32.1.95","volume":"32","author":"Y Seok","year":"2012","unstructured":"Seok Y, Kim J, Choi JR, Kim YR, Park SJ, Kim SJ, Song J, Lee KA. CD5-negative blastoid variant mantle cell lymphoma with complex CCND1\/IGH and MYC aberrations. Ann Lab Med. 2012;32:95\u20138.","journal-title":"Ann Lab Med"},{"key":"526_CR5","doi-asserted-by":"publisher","first-page":"1563","DOI":"10.1080\/1042819021000002884","volume":"43","author":"T Stankovic","year":"2002","unstructured":"Stankovic T, Stewart CS, Byrd P, Fegan C, Moss PAH, Taylor AMR. ATM mutations in sporadic lymphoid tumours. Leuk Lymph. 2002;43:1563\u201371.","journal-title":"Leuk Lymph"},{"key":"526_CR6","doi-asserted-by":"publisher","first-page":"3262","DOI":"10.1182\/blood.V94.9.3262","volume":"94","author":"S Stilgenbauer","year":"1999","unstructured":"Stilgenbauer S, Winkler O, Ou G, Schaffner C, Leupolt E, Bentz M, et al. Molecular characterization of 11q deletions points to a pathogenic role of the ATM gene in mantle cell lymphoma. Blood. 1999;94:3262\u20134.","journal-title":"Blood"},{"key":"526_CR7","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1586\/14737159.2015.975213","volume":"15","author":"BD Webb","year":"2015","unstructured":"Webb BD, Scharf RJ, Spear EA, Edelmann LJ, Stroustrup A. Evaluation of the Affymetrix Cytoscan\u00ae Dx assay for developmental delay. Expert Rev Mol Diagn. 2015;15:185\u201392.","journal-title":"Expert Rev Mol Diagn"},{"key":"526_CR8","volume-title":"An international system for human cytogenomic nomenclature","author":"J McGowan-Jordan","year":"2016","unstructured":"McGowan-Jordan J, Simons A, Schmid M. An international system for human cytogenomic nomenclature. Basel: Karger; 2016."},{"key":"526_CR9","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1038\/nm.2988","volume":"18","author":"AJ Holland","year":"2012","unstructured":"Holland AJ, Cleveland DW. Chromoanagenesis and cancer: mechanisms and consequences of localized, complex chromosomal rearrangement. Nat Med. 2012;18:1630\u20138.","journal-title":"Nat Med"},{"issue":"1","key":"526_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cell.2010.11.055","volume":"144","author":"PJ Stephens","year":"2011","unstructured":"Stephens PJ, Greenman CD, Fu B, Yang F, Bignell GR, Mudie LJ, et al. Massive genomic rearrangement acquired in a single catastrophic event during cancer development. Cell. 2011;144(1):27\u201340.","journal-title":"Cell"},{"issue":"6","key":"526_CR11","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.cell.2011.07.042","volume":"146","author":"P Liu","year":"2011","unstructured":"Liu P, Erez A, Sreenath Nagamani SC, Dhar SU, Kolodziejska KE, Dharmadhikari AV, et al. Chromosome catastrophes involve replication mechanisms generating complex genomic rearrangements. Cell. 2011;146(6):889\u2013903.","journal-title":"Cell"},{"issue":"2","key":"526_CR12","doi-asserted-by":"publisher","first-page":"438","DOI":"10.18632\/oncotarget.1686","volume":"5","author":"J McEvoy","year":"2014","unstructured":"McEvoy J, Nagahawatte P, Finkelstein D, Richards-Yutz J, Valentine M, Ma J, et al. RB1 gene inactivation by chromothripsis in human retinoblastoma. Oncotarget. 2014;5(2):438\u201350.","journal-title":"Oncotarget"},{"key":"526_CR13","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.canlet.2016.10.013","volume":"384","author":"C-C Yu","year":"2017","unstructured":"Yu C-C, Qui W, Juang CS, Mansukhani MM, Halmos B, Su GH. Mutant allele specific imbalance in oncogenes with copy number alterations: occurrence, mechanisms, and potential clinical implications. Cancer Lett. 2017;384:86\u201393.","journal-title":"Cancer Lett"}],"container-title":["Molecular Cytogenetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-020-00526-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13039-020-00526-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13039-020-00526-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,4]],"date-time":"2021-02-04T16:04:30Z","timestamp":1612454670000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularcytogenetics.biomedcentral.com\/articles\/10.1186\/s13039-020-00526-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,4]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["526"],"URL":"https:\/\/doi.org\/10.1186\/s13039-020-00526-x","relation":{},"ISSN":["1755-8166"],"issn-type":[{"type":"electronic","value":"1755-8166"}],"subject":[],"published":{"date-parts":[[2021,2,4]]},"assertion":[{"value":"21 October 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable since this is a case report and no patient identifiers are used.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"8"}}